Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

NCT00022594 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: liposomal lurtotecan

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC